Pharma & Biotech - Page 18

Takeda has secured FDA approval for Orzeyful, a twice-daily tablet treating narcolepsy type 1 in adults, making it the first medicine of its kind. Unlike existing narcolepsy treatments that address symptoms, Orzeyful

AstraZeneca and Bristol Myers Squibb have seen days of intense merger speculation brought to an abrupt halt by a senior source close to the matter. A person familiar with the situation told

Sarepta Therapeutics has appointed Michael Severino, M.D., as its new chief executive, effective July 28, replacing longtime leader Doug Ingram. Ingram announced his planned retirement citing what he described as an “ironic

CVS Health (CVS) is overhauling its direct-to-consumer weight management programme, cutting the price of MinuteClinic weight-management visits to just $29 per appointment. The healthcare giant is also rolling out pharmacist support across

Fujifilm Biotechnologies has announced a significant leadership transition, naming Maja Pedersen as President in addition to her existing role as Chief Operating Officer. The appointment takes effect immediately and marks a deliberate

ViiV Healthcare, the global specialist HIV company majority owned by GSK (GSK), has launched a new multichannel campaign called “Do It For Future You” aimed at encouraging people to act on their

AstraZeneca (AZN) and CSPC Pharmaceutical Group have signed a joint venture contract to construct a new-generation biologics manufacturing facility in Shijiazhuang, China. The agreement marks the third strategic deal the two companies

Moderna has secured a landmark FDA approval for mFlusiva, its mRNA-based influenza vaccine, marking the first time mRNA technology has been cleared for flu prevention in the United States. The approval covers

Emergent BioSolutions has undergone a series of sweeping restructuring efforts, eliminating senior roles and consolidating operations as part of a broad turnaround strategy. Joseph Papa, just two months into his role as

Kenco, one of the United States’ leading third-party logistics providers, has rolled out AI agents across its enterprise operations in a move drawing significant industry attention. The company deployed DeepFabric AI agents